EDSA: Edesa Biotech Inc Kompaniya qiymatining sof foydaga nisbati
Edesa Biotech, Inc. (EDSA) kotirovkalarining -1.90 metriki bilan vizual ifodalanishi biofarmatsevtika biznesining dinamikasini namoyish etadi. Kompaniyaning istiqbollari og'ir o'pka jarohatlarini davolashda EB05 ning samaradorligiga bog'liq. Xatarlar teri va nafas olish a'zolari uchun keng ko'lamli ishlanmalar orqali yumshatiladi. Biroq, tijorat mahsulotlarining yo'qligi pul oqimini nolga tushiradi, bu esa tuzilmaning yashab qolishini butunlay tashqi moliyalashtirishga bog'liq qiladi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261111&filename=GURU_Markets_-_EDSA_-_Edesa-Biotech-Inc._-_PE-Multiple "EDSA: Edesa Biotech, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
Edesa (EDSA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Edesa Biotech, Inc.|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Edesa Biotech Corp|EDSA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Edesa Biotech, Inc.|EDSA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Edesa Biotech|Shoshilinch likvidlik edesabiotech.com
- foyda va bozor multiplikatorlari tafsilotlari:
EDSA - Sof foyda|Sof foyda prognozi Edesa Biotech, Inc.|EDSA - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Edesa Biotech Inc|EDSA - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Edesa Biotech, Inc.|EDSA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Edesa Biotech|EDSA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi edesabiotech.com|EDSA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Edesa Biotech, Inc.
Kompaniyaning har tomonlama tahlili:edesabiotech.com EDSA
Yallig'lanish kasalliklari uchun terapiya vositalarini ishlab chiqishga e'tibor qaratgan Edesa Biotech, Inc. (EDSA) kompaniyasi uchun P/E koeffitsiyenti klinik sinovlarning muvaffaqiyati va kelgusidagi tartibga soluvchi organlar tomonidan tasdiqlanishiga oid bozor kutuvlarini aks ettiradi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini yillik sof foyda bilan solishtiradi, bu esa investorlarga foydaning har bir birligi uchun sarflangan xarajatni baholash va aktivning haqiqiy moliyaviy natijalariga nisbatan qanchalik hadda haddan tashqari sotib olinganligini aniqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tourmaline|PGEN: P/E multiplikatori|Narx-foyda multiplikatori PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Upstream Bio, Inc. UPB|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Biznesning o‘zini qoplash muddati Immunome Bio|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|P/E multiplikatori kalvista.com KALV|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA: P/E multiplikatori|RIGL (Rigel Corp) - Narxning foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati tizianalifesciences.com|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - P/E multiplikatori|AVTX: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|AGEN (agenusbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CLYM (Climb Bio)|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|ATYR - Narxning foydaga nisbati|ADAG (Adagene) - Narx-foyda multiplikatori|IMA: P/E multiplikatori|Narx-foyda koeffitsiyenti Shattuck Labs|Narx-foyda koeffitsiyenti EQ|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori IMUX|ATRA - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori IFRX (InflaRx)|XFOR: Narx-foyda multiplikatori|ACET - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Celularity Inc. CELU|INMB: P/E multiplikatori|Barinthus Biotherapeutics Corp (BRNS) - P/E multiplikatori|Narxning foydaga nisbati Kezar Life Sciences|sabbiotherapeutics.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori AKTX|ENLV (enlivex.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|P/E multiplikatori GeoVax Corp GOVX|IBIO - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|THRD: P/E multiplikatori
